Physician profile
Bindumole Sukumar
NPI 1306450390
$302.03
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.52 · 2022: $118 · 2023: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $168.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.79 | 2022 | |
| Kestra Medical Technology Services, INC. | $30.75 | 2023 | Assure Wcd |
| Optinose US, INC. | $24.82 | 2023 | |
| Vbi Vaccine (Delaware) INC. | $23.60 | 2023 | Prehevbrio |
| Pfizer INC. | $22.14 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $21.50 | 2022 | |
| Exact Sciences Corporation | $20.17 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $16.16 | 2023 | |
| Glaxosmithkline, LLC. | $15.66 | 2023 | Arexvy, Shingrix |
| Amgen INC. | $15.52 | 2021 | |
| Dexcom, INC. | $14.92 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bindumole Sukumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.